145 related articles for article (PubMed ID: 10921459)
1. Monoclonal antibodies and synthetic peptides define the active site of FcepsilonRI and a potential receptor antagonist.
Rigby LJ; Trist H; Snider J; Hulett MD; Hogarth PM; Rigby LJ; Epa VC
Allergy; 2000 Jul; 55(7):609-19. PubMed ID: 10921459
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal part of FcepsilonRIalpha contributes to human IgE and antibody binding--implications for a general structural motif in Fc receptors.
Nechansky A; Aschauer H; Kricek F
FEBS Lett; 1998 Dec; 441(2):225-30. PubMed ID: 9883889
[TBL] [Abstract][Full Text] [Related]
4. Anti-human IgE monoclonal antibodies recognizing epitopes related to the binding sites of high and low affinity IgE receptors.
Takemoto H; Nishimura S; Kosada Y; Hata S; Takagi S; Hosoi S; Ezumi K; Ide M; Harada S
Microbiol Immunol; 1994; 38(1):63-71. PubMed ID: 7519718
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody.
Rudolf MP; Zuercher AW; Nechansky A; Ruf C; Vogel M; Miescher SM; Stadler BM; Kricek F
J Immunol; 2000 Jul; 165(2):813-9. PubMed ID: 10878355
[TBL] [Abstract][Full Text] [Related]
6. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
[TBL] [Abstract][Full Text] [Related]
7. Characterization of FcR Ig-binding sites and epitope mapping.
Hogarth PM; Ierino FL; Hulett MD
Immunomethods; 1994 Feb; 4(1):17-24. PubMed ID: 7520815
[TBL] [Abstract][Full Text] [Related]
8. Epitope analysis and primary structures of variable regions of anti-human FcepsilonRI monoclonal antibodies, and expression of the chimeric antibodies fused with human constant regions.
Takai T; Yuuki T; Iwamoto-Yasue N; Okumura K; Ra C
Biosci Biotechnol Biochem; 2000 Sep; 64(9):1856-67. PubMed ID: 11055388
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23).
Chrétien I; Helm BA; Marsh PJ; Padlan EA; Wijdenes J; Banchereau J
J Immunol; 1988 Nov; 141(9):3128-34. PubMed ID: 2459242
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of IgE-dependent histamine release from human peripheral blood basophils by humanized Fab fragments that recognize the membrane proximal domain of the human Fc epsilon RI alpha-chain.
Takai T; Yuuki T; Ra C
Int Arch Allergy Immunol; 2000 Dec; 123(4):308-18. PubMed ID: 11146388
[TBL] [Abstract][Full Text] [Related]
11. The Fc receptor (FcR) gamma subunit is essential for IgE-binding activity of cell-surface expressed chimeric receptor molecules constructed from human high-affinity IgE receptor (Fc epsilon RI) alpha and FcR gamma subunits.
Suzuki K; Hirose T; Matsuda H; Hasegawa S; Okumura K; Ra C
Mol Immunol; 1998 Apr; 35(5):259-70. PubMed ID: 9747886
[TBL] [Abstract][Full Text] [Related]
12. Convergent recognition of the IgE binding site on the high-affinity IgE receptor.
Stamos J; Eigenbrot C; Nakamura GR; Reynolds ME; Yin J; Lowman HB; Fairbrother WJ; Starovasnik MA
Structure; 2004 Jul; 12(7):1289-301. PubMed ID: 15242605
[TBL] [Abstract][Full Text] [Related]
13. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
14. Domain one of the high affinity IgE receptor, FcepsilonRI, regulates binding to IgE through its interface with domain two.
Rigby LJ; Epa VC; Mackay GA; Hulett MD; Sutton BJ; Gould HJ; Hogarth PM
J Biol Chem; 2000 Mar; 275(13):9664-72. PubMed ID: 10734118
[TBL] [Abstract][Full Text] [Related]
15. Fine specificity of the IgE interaction with the low and high affinity Fc receptor.
Nissim A; Schwarzbaum S; Siraganian R; Eshhar Z
J Immunol; 1993 Feb; 150(4):1365-74. PubMed ID: 7679426
[TBL] [Abstract][Full Text] [Related]
16. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
17. Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions.
Schwarzbaum S; Nissim A; Alkalay I; Ghozi MC; Schindler DG; Bergman Y; Eshhar Z
Eur J Immunol; 1989 Jun; 19(6):1015-23. PubMed ID: 2473907
[TBL] [Abstract][Full Text] [Related]
18. Ca2+-dependent structural changes in the B-cell receptor CD23 increase its affinity for human immunoglobulin E.
Yuan D; Keeble AH; Hibbert RG; Fabiane S; Gould HJ; McDonnell JM; Beavil AJ; Sutton BJ; Dhaliwal B
J Biol Chem; 2013 Jul; 288(30):21667-77. PubMed ID: 23775083
[TBL] [Abstract][Full Text] [Related]
19. Affinity improvement of the high-affinity immunoglobulin E receptor by phage display.
Iwasaki A; Doi T; Umetani M; Watanabe M; Suda M; Hattori Y; Nagoya T
Biochem Biophys Res Commun; 2002 Apr; 293(1):542-8. PubMed ID: 12054635
[TBL] [Abstract][Full Text] [Related]
20. Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor.
Kim B; Eggel A; Tarchevskaya SS; Vogel M; Prinz H; Jardetzky TS
Nature; 2012 Nov; 491(7425):613-7. PubMed ID: 23103871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
